Morgan Stanley »

Tg Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $27M 1.5M 17.79
2024-03-31 $18M 1.2M 15.21
2023-12-31 $25M 1.5M 17.08
2023-09-30 $16M 1.9M 8.36
2023-06-30 $42M 1.7M 24.84
2022-12-31 $9.2M 774k 11.83
2022-06-30 $7.6M 1.9M 3.98
2022-03-31 $10M 1.1M 9.51
2021-06-30 $12M 301k 38.81
2020-12-31 $13M 254k 52.02
2020-09-30 $3.7M 140k 26.75
2020-06-30 $3.2M 162k 19.48
2020-03-31 $3.1M 313k 9.84
2019-12-31 $3.5M 312k 11.10
2019-09-30 $1.2M 219k 5.60
2019-03-31 $619k 77k 8.06
2018-12-31 $2.7M 654k 4.10
2018-09-30 $996k 178k 5.60
2018-06-30 $3.2M 247k 13.15
2018-03-31 $2.2M 158k 14.20
2017-12-31 $1.5M 180k 8.20
2017-03-31 $1.2M 105k 11.66
2016-12-31 $580k 125k 4.65
2016-09-30 $799k 103k 7.73
2016-06-30 $314k 51k 6.17
2016-03-31 $610k 72k 8.52
2015-12-31 $557k 47k 11.98
2015-09-30 $583k 58k 10.07
2015-06-30 $985k 60k 16.54
2014-12-31 $1.1M 70k 15.83
2014-09-30 $213k 20k 10.73
2014-06-30 $176k 19k 9.35
2014-03-31 $769k 111k 6.90
2013-12-31 $6.0k 1.6k 3.66